Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Walther

Showing results (51-60 of 706) with videos related to

Pageof 71
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 22, 2012
Symetis ACURATE TA valveJörg Kempfert, Helge Möllmann, Thomas Walther
The Journal of Physical Chemistry. B|July 21, 2006
Photofragmentation of phase-transferred gold nanoparticles by intense pulsed laser lightZhangquan Peng, Thomas Walther, Karl Kleinermanns
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 21, 2010
The utility of trans-catheter aortic valve replacement after commercialization: does the European experience provide a glimpse into the future use of this technology in the United States?Axel Linke, Thomas Walther, Gerhard Schuler
Biochemical and Biophysical Research Communications|January 19, 2002
Imprinting of the murine MAS protooncogene is restricted to its antisense RNANatalia Alenina, Michael Bader, Thomas Walther
Chemistryopen|September 24, 2025
The Performance of Commercial pH-Sensitive Ion-Selective Field Effect TransistorsNandor Ziebart, Alexander Gießel, Thomas Walther
The Annals of Thoracic Surgery|December 24, 2016
ReplyDaniela Serio, Mirko Doss, Thomas Walther
The Journal of Thoracic and Cardiovascular Surgery|November 8, 2015
Preimplantation valvuloplasty in transcatheter aortic valve replacement: To BAV or not to BAV?Mani Arsalan, John J Squiers, Thomas Walther
Molecular & Cellular Oncology|October 7, 2021
Combining VEGF receptor inhibitors and angiotensin-(1-7) to target renal cell carcinomaThomas Walther, Prateek Khanna, Rupal S Bhatt
Expert Review of Medical Devices|November 19, 2005
Anastomotic devices for coronary artery bypass graftingVolkmar Falk, Thomas Walther, Jan F Gummert
Journal of Clinical Medicine|April 3, 2021
Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 PandemicSamuel N Heyman, Thomas Walther, Zaid Abassi
Pageof 71

Showing results (51-60 of 706) with videos related to

Sort By:
Pageof 71
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 22, 2012
Symetis ACURATE TA valveJörg Kempfert, Helge Möllmann, Thomas Walther
The Journal of Physical Chemistry. B|July 21, 2006
Photofragmentation of phase-transferred gold nanoparticles by intense pulsed laser lightZhangquan Peng, Thomas Walther, Karl Kleinermanns
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 21, 2010
The utility of trans-catheter aortic valve replacement after commercialization: does the European experience provide a glimpse into the future use of this technology in the United States?Axel Linke, Thomas Walther, Gerhard Schuler
Biochemical and Biophysical Research Communications|January 19, 2002
Imprinting of the murine MAS protooncogene is restricted to its antisense RNANatalia Alenina, Michael Bader, Thomas Walther
Chemistryopen|September 24, 2025
The Performance of Commercial pH-Sensitive Ion-Selective Field Effect TransistorsNandor Ziebart, Alexander Gießel, Thomas Walther
The Annals of Thoracic Surgery|December 24, 2016
ReplyDaniela Serio, Mirko Doss, Thomas Walther
The Journal of Thoracic and Cardiovascular Surgery|November 8, 2015
Preimplantation valvuloplasty in transcatheter aortic valve replacement: To BAV or not to BAV?Mani Arsalan, John J Squiers, Thomas Walther
Molecular & Cellular Oncology|October 7, 2021
Combining VEGF receptor inhibitors and angiotensin-(1-7) to target renal cell carcinomaThomas Walther, Prateek Khanna, Rupal S Bhatt
Expert Review of Medical Devices|November 19, 2005
Anastomotic devices for coronary artery bypass graftingVolkmar Falk, Thomas Walther, Jan F Gummert
Journal of Clinical Medicine|April 3, 2021
Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 PandemicSamuel N Heyman, Thomas Walther, Zaid Abassi
Pageof 71